Subscribe
Healthcare

Vaccine experts question fourth shot as companies seek expanded authorization

By Cassidy Morrison
Published
Add Washington Examiner on Google
Vaccine experts question fourth shot as companies seek expanded authorization

COVID-19 vaccine makers’ requests to authorize another round of booster shots have prompted a debate splitting the pharmaceutical companies and vaccine experts who say a fourth jab is not yet needed.

Pfizer and partner company BioNTech, as well as Moderna, the makers of the two-dose mRNA vaccines, have each requested expanded use authorization from federal regulators to administer another round of booster shots to adults, bringing the total number of shots to four.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Atlanta Centers for Disease Control and Prevention COVID-19 FDA Infectious Disease Pfizer Vaccines Washington D.C.